We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
Cap. Flow
+$861M
Cap. Flow %
2.55%
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Financials 14.18%
3 Technology 13.8%
4 Industrials 10.4%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TI
2851
DELISTED
Telecom Italia
TI
$140K ﹤0.01%
17,158
+4,200
+32% +$39.6K
BOOM icon
2852
DMC Global
BOOM
$139M
$138K ﹤0.01%
+12,849
New +$121K
HIL
2853
DELISTED
Hill International, Inc. Common Stock
HIL
$138K ﹤0.01%
33,903
-16,510
-33% -$67.5K
FPI
2854
Farmland Partners
FPI
$407M
$137K ﹤0.01%
+12,098
New +$133K
NGVC icon
2855
Vitamin Cottage Natural Grocers
NGVC
$739M
$137K ﹤0.01%
+10,478
New +$155K
PBR.A icon
2856
Petrobras Class A
PBR.A
$110B
$137K ﹤0.01%
23,510
+900
+4% +$4.65K
NAGE
2857
Niagen Bioscience
NAGE
$272M
$136K ﹤0.01%
+32,901
New +$156K
ICD
2858
DELISTED
Independence Contract Drilling, Inc.
ICD
$136K ﹤0.01%
1,253
+230
+22% +$20.9K
ACGN
2859
DELISTED
Aceragen Inc
ACGN
$135K ﹤0.01%
650
+6
+0.9% +$1.32K
PFNX
2860
DELISTED
Pfenex Inc.
PFNX
$135K ﹤0.01%
16,179
+570
+4% +$4.61K
PDSB icon
2861
PDS Biotechnology
PDSB
$38.6M
$134K ﹤0.01%
+663
New +$117K
RCKT icon
2862
Rocket Pharmaceuticals
RCKT
$340M
$134K ﹤0.01%
+4,502
New +$158K
AXGN icon
2863
Axogen
AXGN
$2.27B
$132K ﹤0.01%
+19,210
New +$109K
ESCA icon
2864
Escalade
ESCA
$272M
$132K ﹤0.01%
12,880
-2,860
-18% -$30.9K
KONA
2865
DELISTED
Kona Grill, Inc.
KONA
$132K ﹤0.01%
+12,313
New +$154K
CTLP
2866
DELISTED
Cantaloupe
CTLP
$131K ﹤0.01%
+30,572
New +$131K
APIC
2867
DELISTED
Apigee Corporation Common Stock
APIC
$131K ﹤0.01%
+10,722
New +$114K
PSG
2868
DELISTED
Performance Sports Group Ltd.
PSG
$131K ﹤0.01%
43,742
-21,463
-33% -$71K
NETI
2869
DELISTED
Eneti Inc.
NETI
$130K ﹤0.01%
5,002
+779
+18% +$25.8K
FNWB icon
2870
First Northwest Bancorp
FNWB
$109M
$129K ﹤0.01%
+10,136
New +$132K
GUID
2871
DELISTED
Guidance Software, Inc.
GUID
$127K ﹤0.01%
20,500
+1,400
+7% +$7.44K
FNM
2872
DELISTED
FANNIE MAE
FNM
$127K ﹤0.01%
63,500
LCTX icon
2873
Lineage Cell Therapeutics
LCTX
$272M
$126K ﹤0.01%
55,071
+6,024
+12% +$14.8K
TOVX icon
2874
Theriva Biologics
TOVX
$9.73M
$126K ﹤0.01%
+8
New +$151K
FMNB icon
2875
Farmers National Banc Corp
FMNB
$939M
$125K ﹤0.01%
+14,167
New +$129K

Similar funds

RhumbLine Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
  • RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
  • RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
  • RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
  • RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.